Review Reports
- Kurtulus Gokduman 1,2 and
- Asiye Gok Yurttas 3,*
Reviewer 1: Anonymous Reviewer 2: Anonymous
Round 1
Reviewer 1 Report
Comments and Suggestions for AuthorsIt was a research article about the combination application of activatable liposome nanoparticles and cisplatin to overcome the resistance of cancer cells against cisplatin and enhance its therapeutic effectiveness. Here are some comments on this study that should be considered before publication:
- Please do not use too long sentences; you can divide them into two or more separate sentences.
- The last paragraph of the introduction is incomplete.
- There are some typos and grammatical mistakes in the text that should be corrected.
- Please explain the method of fabricating liposomes in a better manner.
- Please rewrite and improve sections 2.6 and 3.1.
- “Cleavage of disulfide bonds of disulfide-bridged dimeric … reagent with similar activity to GSH for disulfide bond cleavage [24, 26] 191 (Fig. 2).” This paragraph should be written under a new sub-heading and needs to be explained better.
- Please explain more about the results of Figure 3. The same for Figures 4 and 5. You have to explain the results in the main text, not just in the Figure caption.
- Why do the results of the MTT assay show better toxicity effect in lower concentrations of Cisplatin compared to its higher concentrations (Figure 4)?
- It is not normal to use references in the conclusion section. You have to add those references, along with the comparison of your results with previous studies, to the discussion section.
- Please update the references; there is no reference related to 2023-2025 in your manuscript.
Author Response
Response to Reviewer Comments
We sincerely thank the reviewer for their detailed and constructive evaluation of our manuscript. Each comment has been carefully considered and addressed as outlined below. All modifications have been incorporated into the revised manuscript and are indicated accordingly.
Comment 1: Please do not use too long sentences; you can divide them into two or more separate sentences.
We thank the reviewer for this stylistic observation. The manuscript has been carefully revised throughout to eliminate excessively long and complex sentences. Where necessary, compound sentences have been divided into two or more concise, independent statements to improve readability and clarity. These revisions have been applied uniformly across all sections of the manuscript.
Comment 2: The last paragraph of the introduction is incomplete.
We apologize for this oversight. The final paragraph of the Introduction has been completed and expanded to provide a clear statement of the study's objectives, the rationale for the combined application of activatable liposome nanoparticles with cisplatin, and a brief outline of the experimental approach.
Comment 3: There are some typos and grammatical mistakes in the text that should be corrected.
The entire manuscript has been carefully proofread. All identified typographical errors and grammatical inconsistencies have been corrected. A professional language editing service was additionally consulted to ensure linguistic accuracy throughout the revised manuscript.
Comment 4: Please explain the method of fabricating liposomes in a better manner.
We agree that the liposome fabrication methodology required a more detailed and systematic description. The Methods section has been substantially revised to provide a comprehensive account of the preparation procedure.
Comment 5: Please rewrite and improve sections 2.6 and 3.1.
Both sections have been substantially rewritten to improve clarity, methodological detail, and logical flow.
Comment 6: The paragraph on cleavage of disulfide bonds should be written under a new sub-heading and explained better.
We agree with the reviewer's suggestion. This paragraph has been reorganized under a dedicated sub-heading and substantially expanded to provide a more comprehensive mechanistic explanation.
Comment 7: Please explain more about the results of Figures 3, 4, and 5 in the main text.
We acknowledge that the results of Figures 3, 4, and 5 were insufficiently discussed in the main text. Detailed descriptions and interpretations of these figures have been incorporated into the Results section.
Comment 8: Why do the results of the MTT assay show better toxicity effect in lower concentrations of cisplatin compared to higher concentrations?
We thank the reviewer for raising this important point. This observation is indeed noteworthy and warrants a mechanistic explanation.
Comment 9: It is not normal to use references in the conclusion section.
We agree with this observation. All references previously cited in the Conclusion section have been removed from that section and relocated to the Discussion section, where they have been incorporated alongside a systematic comparison of our findings with those of previously published studies.
Comment 10: Please update the references; there is no reference related to 2023–2025 in your manuscript.
We acknowledge this limitation. The reference list has been thoroughly reviewed and updated to include recent publications from 2023 to 2025 that are directly relevant to the key topics addressed in the manuscript, including cisplatin resistance mechanisms, stimuli-responsive nanoparticle systems, liposomal drug delivery, and GSH-triggered drug release.
*We hope that the comprehensive revisions and additions detailed above adequately address all of the reviewer's concerns. We remain available to provide any further clarification that may be required during the review process.
Author Response File:
Author Response.docx
Reviewer 2 Report
Comments and Suggestions for AuthorsThe manuscript under review investigates the anticancer effects of cisplatin combined with redox-responsive phthalocyanine-loaded liposomes for photodynamic therapy in MCF-7 breast cancer cells. The study addresses an important challenge in overcoming chemoresistance and improving therapeutic selectivity through combinational nanomedicine approaches. The topic is relevant and promising; however, the manuscript cannot be published in its current form. Several aspects of the experimental design, data presentation, and interpretation require clarification and improvement according to the following comments.
Comment 1:
The introduction provides adequate background on cisplatin resistance and photodynamic therapy; however, the novelty of the proposed nanoplatform is not sufficiently emphasized. The authors should better differentiate their system from previously reported glutathione-responsive liposomal or phthalocyanine-based delivery systems and clearly state the specific scientific advancement achieved in this work.
Comment 2:
The characterization of the liposomal formulation is incomplete. Important physicochemical parameters such as long-term colloidal stability, polydispersity reproducibility, encapsulation efficiency calculations, and release kinetics under physiologically relevant conditions should be described in more detail. In addition, the irradiation conditions require clearer reporting, including light intensity, exposure homogeneity, and justification for the selected irradiation dose.
Comment 3:
The particle characterization data require deeper interpretation. The manuscript does not sufficiently discuss how size and zeta potential parameters may influence cellular uptake, circulation stability, or therapeutic performance. Transmission electron microscopy or Scanning electron microscopy images should be provided and supported with quantitative size distribution analysis to confirm consistency with DLS measurements.
Comment 4:
The biological results section needs substantial clarification and strengthening. The cytotoxicity experiments should include clearer comparisons between all treatment groups, particularly free cisplatin, empty liposomes, non-irradiated formulations, irradiated controls, and combination treatments.
Furthermore, intracellular ROS generation and glutathione depletion results should be correlated more directly with cell viability outcomes to support the proposed mechanism of action. The apoptosis-related findings would also benefit from additional mechanistic markers to confirm whether cell death occurs predominantly through apoptotic or oxidative stress-mediated pathways.
Comment 5:
The manuscript would benefit from a dedicated limitations paragraph discussing the absence of animal studies, long-term toxicity assessment, and evaluation in resistant cancer models.
Author Response
Response to Reviewer Comments
We sincerely thank the reviewer for their thorough and constructive evaluation of our manuscript. The comments provided have allowed us to substantially strengthen the scientific rigor, clarity, and completeness of the work. Each comment has been carefully addressed below, and all corresponding revisions and additions have been incorporated into the revised manuscript.
Comment 1: The novelty of the proposed nanoplatform is not sufficiently emphasized. The authors should better differentiate their system from previously reported glutathione-responsive liposomal or phthalocyanine-based delivery systems and clearly state the specific scientific advancement achieved in this work.
We thank the reviewer for this important observation. We agree that the novelty of our system was not sufficiently highlighted in the original manuscript. The Introduction has been revised to explicitly differentiate our nanoplatform from previously reported glutathione-responsive liposomal and phthalocyanine-based delivery systems, and to clearly articulate the specific scientific contributions of the present work.
Comment 2: The characterization of the liposomal formulation is incomplete. Important physicochemical parameters such as long-term colloidal stability, polydispersity reproducibility, encapsulation efficiency calculations, and release kinetics under physiologically relevant conditions should be described in more detail. Irradiation conditions also require clearer reporting.
Response: We thank the reviewer for highlighting these critical parameters. In this revised manuscript, we have provided a detailed account of the irradiation conditions to ensure experimental reproducibility and clarity, as these parameters are essential for the photodynamic performance of our system.
Regarding the remaining physicochemical characterization parameters (long-term colloidal stability, encapsulation efficiency, and detailed release kinetics), we would like to clarify that, due to technical constraints during this study, we were unable to perform these specific longitudinal and quantitative characterizations. We acknowledge that the lack of this comprehensive data is a limitation of our work. To address this, we have now explicitly included a dedicated "Limitations" paragraph in the Discussion section to transparently discuss these points and their potential impact on the clinical translation of our platform. We appreciate the reviewer’s understanding regarding the scope of our current findings and believe that the clarification of the irradiation protocol significantly improves the manuscript.
Comment 3: The particle characterization data require deeper interpretation. TEM or SEM images should be provided, and how size and zeta potential influence cellular uptake, circulation stability, and therapeutic performance should be discussed.
Response: We thank the reviewer for this constructive suggestion regarding the interpretation of our physicochemical data. In this revised manuscript, we have significantly expanded the Discussion section to provide a detailed analysis of how particle size and zeta potential influence cellular uptake, circulation stability, and overall therapeutic performance.
Regarding the request for TEM or SEM images, we regret that we were unable to incorporate electron microscopy analysis into the current study due to technical limitations in our imaging facility. We recognize that this is a deficiency in our characterization data. Accordingly, we have added a dedicated "Limitations" paragraph to the Discussion section to explicitly acknowledge the absence of direct morphological visualization of the nanoparticles and its impact on the scope of our morphological characterization. We believe that the inclusion of the detailed theoretical discussion on size and charge dynamics provides a robust scientific rationale for the observed biological performance of our nanoplatform.
Comment 4: The biological results section needs substantial clarification. Cytotoxicity comparisons should include all treatment groups. ROS generation and GSH depletion results should be correlated with cell viability. Apoptosis findings require additional mechanistic markers.
Response: We thank the reviewer for these suggestions. We have systematically revised the biological results section to include comprehensive comparisons across all groups. Regarding the mechanistic investigation of GSH depletion, we have now clarified that the GSH-responsive behavior of ASG20 was validated using dithiothreitol (DTT) as a surrogate for intracellular glutathione, in accordance with established literature [24]. We have correlated these biochemical findings with our cytotoxicity data, demonstrating that the GSH-consuming mechanism directly enhances cisplatin sensitivity. While we have utilized Annexin V/PI flow cytometry to characterize the mode of cell death, we acknowledge the absence of additional molecular markers (such as Caspase-3) to further delineate the apoptotic pathway, and have addressed this as a limitation of our current study. We believe the presented data, combined with our mechanistic discussion, robustly substantiates our proposed therapeutic model.
Comment 5: The manuscript would benefit from a dedicated limitations paragraph discussing the absence of animal studies, long-term toxicity assessment, and evaluation in resistant cancer models.
We fully agree with this suggestion. A dedicated limitations paragraph has been added to the Discussion section.
*We hope that the comprehensive revisions, additions, and clarifications provided in response to the reviewer's comments have adequately addressed all concerns raised. We remain available to provide any further information that may be required during the review process.
Author Response File:
Author Response.docx
Round 2
Reviewer 2 Report
Comments and Suggestions for AuthorsThe authors have successfully addressed most of the issues raised in the review report. However, I believe that microscopic characterization of the liposomes using techniques such as TEM, SEM, and/or AFM should also have been provided, together with encapsulation efficiency and detailed release kinetics, as these represent critical characterization parameters for the nanoparticle system used in this study. The authors could be given additional time to perform these analyses; nevertheless, I leave the final decision to the editor.
Author Response
Response to Reviewer:
We sincerely thank the reviewer for this valuable comment and fully agree that detailed physicochemical characterization, including transmission electron microscopy (TEM), scanning electron microscopy (SEM), and/or atomic force microscopy (AFM), as well as encapsulation efficiency and release kinetics analyses, would provide additional insight into the nanoparticle system and further strengthen the study.
The present work was primarily designed to evaluate the biological performance of the liposomal formulation within the scope of the available infrastructure and resources. Although we recognize the importance of these advanced characterization techniques, access to the specialized instrumentation and financial resources required to perform all of these analyses was limited during the study period. Consequently, comprehensive morphological characterization and extended release studies could not be completed within the timeframe of the current investigation.
Nevertheless, the authors acknowledge this limitation and have added a statement to the manuscript addressing the absence of these analyses. We also wish to emphasize that detailed nanoparticle characterization, including TEM/SEM/AFM imaging, encapsulation efficiency determination, and in vitro release profiling, is planned as part of our ongoing and future studies to further validate and expand upon the findings presented here.
We appreciate the reviewer’s thoughtful suggestion, which will help guide the next phase of this research.